Your Partners in Market Access
We are a global consulting firm focused on payer strategy and market access in the pharmaceutical and biotech markets. We work closely with our clients to develop their global value strategy, engage key opinion leaders, generate evidence, and develop pricing strategies that reflect the value of their product.
Health Technology Assessment
Advisory board management
We can help you
Map the natural history and treatment pathway of a disease
Determine unmet need by characterizing the burden of illness
Identify and quantify comparative effectiveness and other outcomes
Develop original or adapted cost-effectiveness models to demonstrate the value of an intervention
Evaluate the value of additional evidence to support product value propositions
From Our Clients
"I have worked with Symmetron on HTAs for NICE and SMC and found the team professional, flexible in responding to my needs and willing to go the extra mile to deliver on our desired outcomes. I look forward to working with them again."
"Symmetron has led the development of several complex economic models for us over several years and has always delivered rigorous research and rock-solid timely results. All output always stood up to HTA scrutiny and what I admired most is how well Symmetron managed not only the development of the model, but also the KOL alignment meetings. A tremendous pleasure to work with and a relaxing experience."